Want to see CTOR full AI Analyst Report?
Citius Oncology (CTOR) Q2 2026 Earnings Report
CTOR Q2 2026 EPS Results
- Actual EPS
- -$0.27
- Consensus EPS
- -$0.01
- Beat/Miss
- Missed by -$0.26
- One Year Ago EPS
- -$0.11
CTOR Q2 2026 Revenue Results
- Actual Revenue
- $1.67M
- Expected Revenue
- $7.00M
- Beat/Miss
- Missed by -$5.33M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 05/15/2026
- Time
- After Close
- Conference Call
- Friday, May 15, 2026
CTOR Upcoming Earnings
Citius Oncology's next earnings date is estimated for December 17, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CTOR Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Dec 17, 2026 | 2026 (Q4) | -0.07- | -0.06 | ― | ― |
| Aug 14, 2026 | 2026 (Q3) | -0.07-0.08 | -0.08 | 0.00% (+0.00) | |
| May 15, 2026 | 2026 (Q2) | -0.01-0.27 | -0.11 | -145.45% (-0.16) | |
| Feb 13, 2026 | 2026 (Q1) | -0.04-0.06 | -0.09 | 33.33% (+0.03) | |
| Dec 23, 2025 | 2025 (Q4) | -0.06-0.06 | ― | ― | |
| Aug 12, 2025 | 2025 (Q3) | -0.15-0.08 | -0.07 | -14.29% (-0.01) | |
| May 14, 2025 | 2025 (Q2) | -0.09-0.11 | ― | ― | |
| Feb 14, 2025 | 2025 (Q1) | -0.06-0.09 | 0.12 | -177.59% (-0.21) | |
| Dec 27, 2024 | 2024 (Q4) | -0.08-0.31 | 0.02 | -1800.00% (-0.32) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
